Geode Capital Management LLC Trims Holdings in SWK Holdings Co. (NASDAQ:SWKH)

Geode Capital Management LLC reduced its position in shares of SWK Holdings Co. (NASDAQ:SWKH) by 9.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 75,306 shares of the company’s stock after selling 7,465 shares during the period. Geode Capital Management LLC owned 0.60% of SWK worth $1,302,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. SkyView Investment Advisors LLC lifted its stake in shares of SWK by 7.7% during the second quarter. SkyView Investment Advisors LLC now owns 31,165 shares of the company’s stock valued at $529,000 after buying an additional 2,234 shares during the period. Barclays PLC raised its holdings in SWK by 185.0% in the 3rd quarter. Barclays PLC now owns 4,461 shares of the company’s stock valued at $77,000 after acquiring an additional 2,896 shares during the last quarter. Bank of New York Mellon Corp purchased a new position in shares of SWK during the 2nd quarter worth $172,000. Dimensional Fund Advisors LP boosted its holdings in shares of SWK by 85.7% during the second quarter. Dimensional Fund Advisors LP now owns 30,109 shares of the company’s stock worth $511,000 after purchasing an additional 13,892 shares during the last quarter. Finally, Victory Capital Management Inc. purchased a new stake in shares of SWK in the third quarter valued at $589,000. 99.27% of the stock is currently owned by hedge funds and other institutional investors.

SWK Stock Performance

SWK stock opened at $16.12 on Friday. The stock has a fifty day moving average price of $16.16 and a 200 day moving average price of $16.71. The company has a current ratio of 5.06, a quick ratio of 5.06 and a debt-to-equity ratio of 0.11. SWK Holdings Co. has a 52 week low of $15.14 and a 52 week high of $18.49. The firm has a market capitalization of $197.20 million, a P/E ratio of 17.33 and a beta of 0.36.

SWK Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.